The Latest Diabetes News
Our news pages are updated monthly with studies and stories we feel are important to share.
advertisement
Current Research News - February 21, 2024
- The interplay between gingival crevicular fluid microbiome and metabolomic profile in intensively treated people with type 1 diabetes – a combined metagenomic/metabolomic approach cross-sectional study
- Interactive calculator to estimate insulin sensitivity in type 1 diabetes
- Safety, tolerability and immunogenicity of PRV-101, a multivalent vaccine targeting coxsackie B viruses (CVBs) associated with type 1 diabetes: a double-blind randomised placebo-controlled Phase I trial
- The use of dietary supplements, and the association between supplemental vitamin D and glycaemic control in adult individuals with type 1 diabetes
- Encapsulation and immune protection for type 1 diabetes cell therapy
- COMPARISON OF C-PEPTIDE LEVELS IN MONOGENIC FORMS OF DIABETES WITH OTHER TYPES OF DIABETES: A SINGLE-CENTER STUDY
- Implementation of type 1 diabetes genetic risk screening in children in diverse communities: the Virginia PrIMeD project
- AWD-stacking: An enhanced ensemble learning model for predicting glucose levels
- Evidence for C-peptide as a Validated Surrogate to Predict Clinical Benefits in Trials of Disease-Modifying Therapies for Type 1 Diabetes
- TYK2 signaling promotes the development of autoreactive CD8+ cytotoxic T lymphocytes and type 1 diabetes
- Candidate Biomarkers for Targeting in Type 1 Diabetes; A Bioinformatic Analysis of Pancreatic Cell Surface Antigens
- Assisting the implementation of screening for type 1 diabetes by using artificial intelligence on publicly available data
Current Complications Research News - February 21, 2024
- Quantifying peripapillary vessel density and retinal nerve fibre layer in type 1 diabetic children without clinically detectable retinopathy using OCTA
- Obesity Treatments to Improve Type 1 Diabetes (OTID): a randomized controlled trial of the combination of glucagon-like peptide 1 analogues and sodium-glucose cotransporter 2 inhibitors-protocol for Obesity Treatments to Improve Type 1 Diabetes (the OTID
- Lower left atrial function in young individuals with type 1 diabetes mellitus compared to healthy controls: an echocardiographic study
- Syringaresinol Alleviates Early Diabetic Retinopathy by Downregulating HIF-1α/VEGF via Activating Nrf2 Antioxidant Pathway
- Age at onset of type 1 diabetes between puberty and 30 years old is associated with increased diabetic nephropathy risk
- Gonadal dysfunction in women with diabetes mellitus
Current Daily Care News - February 21, 2024
- Open-source Artificial Pancreas Systems Are Safe and Effective When Supported In-clinic: Outcomes in 248 Consecutive Type 1 Diabetes Clients
- Tandem T:Slim X2 Insulin Pump Use in Clinical Practice Among Pregnant Individuals With Type 1 Diabetes: A Retrospective Observational Cohort Study
- Retrospective Comparison of Commercially Available Automated Insulin Delivery With Open-Source Automated Insulin Delivery Systems in Type 1 Diabetes
- Hybrid Closed-Loop Versus Manual Insulin Delivery in Adults With Type 1 Diabetes: A Post Hoc Analysis Using the Glycemia Risk Index
- The effect of carbohydrate intake on glycaemic control in individuals with type 1 diabetes: a randomised, open-label, crossover trial
- Efficacy and Safety of Ultra-rapid Lispro Insulin in Managing Type-1 and Type-2 Diabetes: A Systematic Review and Meta-Analysis
- Impact of an online nutrition management application service on glycaemic management in individuals with diabetes: A propensity-score-matched retrospective cohort study
- Assessment of the impact of subcutaneous catheter change on glucose control in patients with type 1 diabetes treated by insulin pump in open- and automated insulin delivery modes
Current Around the DOC news - February 21, 2024
- Hospitalized Children With Diabetes May Be Able to Continue Safe Use of Home Pumps, Suggest Findings
- Spike hype
- As technology improves, increasing CGM access requires education, community support
- Rising medication costs pose barrier to diabetes treatment, study finds
- Diabetes Dialogue: Tirzepatide in Type 1 Diabetes, with Viral Shah, MD
- MannKind Announces Enrollment Goal Completion of INHALE-1 Pediatric Diabetes Trial Utilizing Afrezza®
- Patients With Type 1 Diabetes Not Achieving Glycemic Targets Despite Use of New Technology
- Immunotherapy to treat people with type 1 diabetes genotype granted fast track designation
- Helmsley Charitable Trust Awards Over $12 Million to Projects Aimed at Helping People With Type 1 Diabetes Safely Incorporate Exercise Into Their Daily Lives
- What’s New in the 2024 ADA Standards of Care?
- Glycemic outcomes and patient satisfaction and self-management improves in transition from standard to virtual multidisciplinary care
- Insulin Pump Therapy vs Multiple Daily Insulin Injections for Glycemic Control in Children With Type 1 Diabetes: A Systematic Review and Meta-Analysis
- Type 1 Diabetes Onset Tied to Decreased Complement Protein Levels
- FDA fast tracks Diamyd’s immunotherapy for managing type 1 diabetes
- JDRF Canada and Sanofi Canada partner to raise awareness about autoimmune type 1 diabetes and the critical role of screening in its early detection
Current Celiac News - February 21, 2024
- Prevalence and Predictive Factors for Celiac Disease in Children With Type 1 Diabetes. Whom and When to Screen? A Nationwide Longitudinal Cohort Study of Swedish Children
- Prevalence of coeliac disease in patients with systemic lupus erythematosus: a systematic review and meta-analysis
- Intestinal mRNA expression analysis of polarity-related genes identified the discriminatory ability of CRB3 as a diagnostic marker for celiac disease
- ASSOCIATION BETWEEN CELIAC DISEASE AND IRRITABLE BOWEL SYNDROME: A NATIONWIDE COHORT STUDY
- The influence of carboxymethyl cellulose and hydroxypropyl methylcellulose on physicochemical, texture, and sensory characteristics of gluten-free pancake
- Experiences and perceptions of people with celiac disease, food allergies and food intolerance when dining out
- A look into the future: Are we ready for an approved therapy in celiac disease?
Current Press Releases - September 13, 2023
- Registrational Phase III trial in Type 1 Diabetes with Diamyd® expands to the US
- Sharing the Access Code to Help Open Up Diabetes Care
- Tubeless insulin pump receives FDA clearance for people with diabetes
- Biocon Biologics Continues to Expand Global Footprint, Completes Integration of Viatris Biosimilars’ Business In North America, Ahead of Schedule
Current Legislative & Policy News - February 8, 2023
advertisement